Target intelligence / Profile preview

RASSF3 divergent transcript (RASSF3-DT)

Target: RASSF3-DT
Molecular classification: Other, non-coding RNA

Overview

RASSF3 divergent transcript (RASSF3-DT) is a predicted non-coding RNA gene located near the RASSF3 locus on human chromosome 12 (chr12:64599078-64609459, hg38)[3]. It does not encode a protein and is not established as a receptor, enzyme, transporter, or recognized therapeutic target. There is currently no direct evidence for a functional biological role, association with disease, or clinical application for RASSF3-DT. It is distinct from the protein-coding RASSF3 gene, which is implicated in tumor suppression through p53-dependent apoptosis and cell cycle regulation[1][2]. RASSF3-DT appears primarily in gene annotation databases as an RNA feature without functional annotation[3][7].

Other names: RASSF3-DT

Beyond the preview

Go deeper on RASSF3 divergent transcript (RASSF3-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RASSF3 divergent transcript (RASSF3-DT).

Explore the full profile